Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research

REDWOOD CITY, California, October 19, 2010 - Ingenuity(R) Systems, the leading provider of information solutions for
life science researchers, and TransMed Systems, a translational medicine
software and services company, today announced an integration between IPA(R)
software and XB Bio-Integration Suite (XB-BIS). Researchers can now easily
take pre-clinical and clinical data that is managed and statistically
analyzed by XB-BIS, directly into IPA(R), which is used by researchers to
model, analyze, and explore various types of 'omics data to gain a deeper
understanding of complex biological systems.

The software integration supports academic and commercial researchers who
are studying how genes affect the way individuals respond to drug treatments.
Joint customers will have a clear workflow to analyze pre-clinical and
clinical data in the context of signaling and metabolic pathways, networks,
and cellular processes available in IPA. This approach helps researchers move
rapidly and confidently from hypothesis generation to validation experiments.

Nick Berens, CEO, TransMed Systems, said, "The integration between XB-BIS
and IPA will enable physicians, clinicians and researchers to integrate the
latest biological content, pathways and molecular networks into their
translational medicine and research. These enhanced capabilities will allow
for more timely and informed treatment strategies and practices and improve
personalized medicine."

Doug Bassett, Ph.D., CSO and CTO, Ingenuity Systems, stated,
"Personalized medicine requires the ability to quickly translate large
amounts of data into meaningful biological information. We're very pleased
that our partnership with TransMed will provide a streamlined platform from
which researchers and clinicians will be able to collect and analyze data,
link genotypes to phenotypes, identify potential biomarkers, generate
powerful and informed hypotheses, and understand the molecular differences
between patient populations for improved diagnostics and therapeutics."

About Ingenuity(R) Systems

Ingenuity Systems is a leading provider of information solutions and
custom services for life science researchers, computational biologists and
bioinformaticists, and life science industry suppliers. For more information
visit: www.ingenuity.com

About TransMed Systems

TransMed Systems, was founded as a next generation life science
application and services company with headquarters in Cupertino, California.
The focus of TransMed Systems is to provide leading edge software and service
solutions expediting the complete life science work process from novel
discovery to clinical application in an integrated environment. TransMed
Systems markets its XB Bio-Integration Suite as a fully integrated biological
and medical informatics solution that allows users to generate, refine, and
validate causal hypotheses across disparate data sets. The purpose is to
provide a complete solution in the area of translational biomedical research,
whereby bench-side research can rapidly lead to discoveries that can be
readily applied to bedside medicine. www.xbtransmed.com/

Heidi Bullock, Director, Marketing of Ingenuity Systems, +1-650-381-5150